Allegheny Health Network Implants Central Sleep Apnea Patient with Neurostimulator
The device is implanted under the skin in the upper chest and stimulates the phrenic nerve to regulate breathing.
The device is implanted under the skin in the upper chest and stimulates the phrenic nerve to regulate breathing.
SleepMedRx founder and CEO Jagdeep Bijwadia, MD, MBA, on why recognizing co-existing disorders, such as cardiac comorbidities, should be a priority for sleep specialists.
Researchers say the adjuvant therapy, used with CPAP, has the potential of becoming a valuable and effective treatment targeting OSA-induced morbidities.
The Centers for Medicare and Medicaid Services has established the final HCPCS coding, benefit category determination, and payment determination for eXciteOSA, a daytime therapy for obstructive sleep apnea.
Sleep Review's home sleep testing services comparison guide is a comprehensive look at available programs to help streamline workflows.
Lifesaving equipment is being denied payment because of rigid criteria in local coverage determinations and existing coverage provided by CMS is not reflective of rapidly evolving technology in the field.
Sleep deprivation alone in mice caused only mild cognitive impairment, so what causes the selective degeneration of neurons that characteristically die in dementia?
The companies detail how the new partnership, which combines Sunrise's artificial intelligence solutions and the technologies of eXciteOSA, will improve patient care.